Published in J Clin Psychopharmacol on April 01, 1997
Carbon dioxide inhalation induces dose-dependent and age-related negative affectivity. PLoS One (2007) 0.83
Respiratory, autonomic, and experiential responses to repeated inhalations of 20% CO₂ enriched air in panic disorder, social phobia, and healthy controls. Biol Psychol (2010) 0.80
Experimental panic provocation in healthy man-a translational role in anti-panic drug development? Dialogues Clin Neurosci (2011) 0.76
Effects of tryptophan depletion and tryptophan loading on the affective response to high-dose CO2 challenge in healthy volunteers. Psychopharmacology (Berl) (2011) 0.76
Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet (1999) 1.98
Clostridium perfringens Type A Food Poisoning II. Response of the Rabbit Ileum as an Indication of Enteropathogenicity of Strains of Clostridium perfringens in Human Beings. Infect Immun (1971) 1.73
Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry (2012) 1.57
Modulation by muscarinic antagonists of the response to carbon dioxide challenge in panic disorder. Arch Gen Psychiatry (2001) 1.56
Antibodies against rifampin in patients with tuberculosis after discontinuation of daily treatment. Am Rev Respir Dis (1976) 1.43
[18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment. Br J Psychiatry (1995) 1.23
The Iowa Personality Disorder Screen: development and preliminary validation of a brief screening interview. J Pers Disord (1999) 1.17
Decision-making heterogeneity in obsessive-compulsive disorder: ventromedial prefrontal cortex function predicts different treatment outcomes. Neuropsychologia (2002) 1.15
Clinical predictors of drug response in obsessive-compulsive disorder. J Clin Psychopharmacol (2001) 1.09
Frequency of left atrial thrombi by transesophageal echocardiography in idiopathic and in ischemic dilated cardiomyopathy. Am J Cardiol (1992) 1.05
Disorganization of anatomical connectivity in obsessive compulsive disorder: a multi-parameter diffusion tensor imaging study in a subpopulation of patients. Neurobiol Dis (2009) 1.05
Sensitivity to 35% CO2 in healthy first-degree relatives of patients with panic disorder. Am J Psychiatry (1995) 1.02
The cooccurrence of DSM-III-R personality disorders. J Pers Disord (1998) 1.01
Comparative bioavailability of isoniazid, rifampin, and pyrazinamide administered in free combination and in a fixed triple formulation designed for daily use in antituberculosis chemotherapy. II. Two-month, daily administration study. Am Rev Respir Dis (1988) 0.98
Complex segregation analysis for obsessive compulsive disorder and related disorders. Am J Med Genet (1999) 0.98
CO2-induced panic attacks: a twin study. Am J Psychiatry (1998) 0.96
Age at onset of panic disorder: influence of familial liability to the disease and of childhood separation anxiety disorder. Am J Psychiatry (1995) 0.96
Temperament dimensions explain the comorbidity of psychiatric disorders. Compr Psychiatry (1996) 0.94
Serotonin transporter linked polymorphic region in anorexia nervosa and bulimia nervosa. Mol Psychiatry (2000) 0.93
First-cycle REM density in never-depressed subjects with borderline personality disorder. Biol Psychiatry (1999) 0.93
The unipolar-bipolar dichotomy and the response to sleep deprivation. Psychiatry Res (1998) 0.93
Plasma interleukin-1 beta and tumor necrosis factor concentrations in obsessive-compulsive disorders. Biol Psychiatry (1997) 0.92
Hypersensitivity to inhalation of carbon dioxide and panic attacks. Psychiatry Res (1995) 0.90
Incest and pelvic pain: the social worker as part of a research team. Health Soc Work (1983) 0.88
Predictive value of obsessive-compulsive personality disorder in antiobsessional pharmacological treatment. Eur Neuropsychopharmacol (1997) 0.88
Ambulatory polysomnography of never-depressed borderline subjects: a high-risk approach to rapid eye movement latency. Biol Psychiatry (1993) 0.87
Family history of panic disorder and hypersensitivity to CO2 in patients with panic disorder. Am J Psychiatry (1996) 0.87
A family study of schizotypal disorder. Schizophr Bull (1995) 0.86
Functional promoter polymorphism of the human serotonin transporter: lack of association with panic disorder. Psychiatr Genet (1997) 0.86
Effect of adjuvant pindolol on the antiobsessional response to fluvoxamine: a double-blind, placebo-controlled study. Int Clin Psychopharmacol (1998) 0.86
Asthma and panic attacks. Biol Psychiatry (1997) 0.86
Insomnia as a predictor of high-lethality suicide attempts. Int J Clin Pract (2013) 0.86
The 5-HT(2A) -1438G/A polymorphism in anorexia nervosa: a combined analysis of 316 trios from six European centres. Mol Psychiatry (2002) 0.85
Central dopaminergic function in anorexia and bulimia nervosa: a psychoneuroendocrine approach. Psychoneuroendocrinology (2001) 0.85
Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response. Pharmacogenomics J (2002) 0.85
An association study between 5-HTTLPR polymorphism, COMT polymorphism, and Tourette's syndrome. Psychiatry Res (2000) 0.85
Plasma interleukin-1 beta concentrations in panic disorder. Psychiatry Res (1994) 0.85
Rehabilitation after acute vestibular disorders. J Laryngol Otol (2008) 0.84
Comparison of the treatment with paroxetine and reboxetine in panic disorder: a randomized, single-blind study. Pharmacopsychiatry (2004) 0.84
Panic disorder: the role of the balance system. J Psychiatr Res (2001) 0.84
Vestibular testing in patients with panic disorder and chronic dizziness. Acta Otorhinolaryngol Ital (2007) 0.84
Obsessive compulsive disorder and mood disorders: a family study. Am J Med Genet (1995) 0.84
Alpha 2-adrenergic receptor sensitivity in panic disorder: I. GH response to GHRH and clonidine stimulation in panic disorder. Psychoneuroendocrinology (1995) 0.84
Laboratory response of patients with panic and obsessive-compulsive disorders to 35% CO2 challenges. Am J Psychiatry (1995) 0.84
Physiological and behavioral responses to minor stressors in offspring of patients with panic disorder. J Psychiatr Res (1997) 0.83
EEG power modifications in panic disorder during a temporolimbic activation task: relationships with temporal lobe clinical symptomatology. J Neuropsychiatry Clin Neurosci (1993) 0.83
Frontal lobe dysfunction in schizophrenia and obsessive-compulsive disorder: a neuropsychological study. Brain Cogn (1995) 0.83
Tryptophan depletion in obsessive-compulsive patients. Biol Psychiatry (1996) 0.83
Complex segregation analysis of obsessive-compulsive disorder in 141 families of eating disorder probands, with and without obsessive-compulsive disorder. Am J Med Genet (2000) 0.83
Carbon dioxide/oxygen challenge test in panic disorder. Psychiatry Res (1994) 0.82
A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study. Pharmacopsychiatry (2001) 0.82
Combined family trio and case-control analysis of the COMT Val158Met polymorphism in European patients with anorexia nervosa. Am J Med Genet B Neuropsychiatr Genet (2004) 0.81
The 35% CO2 challenge test in patients with social phobia. Psychiatry Res (1997) 0.81
Pharmacokinetic study on intravenous rifampicin in man. Pharmacol Res Commun (1984) 0.81
Menstrual cycle-related sensitivity to 35% CO2 in panic patients. Biol Psychiatry (1995) 0.81
5HT2C CYS23/SER23 polymorphism is not associated with obsessive-compulsive disorder. Psychiatry Res (1998) 0.81
Frontal lobe dysfunction in obsessive-compulsive disorder and major depression: a clinical-neuropsychological study. Psychiatry Res (1998) 0.81
Borderline syndrome and incest in chronic pelvic pain patients. Int J Psychiatry Med (1980) 0.81
Plasma levels of tumor necrosis factor-alpha in patients with panic disorder: effect of alprazolam therapy. Psychiatry Res (1999) 0.81
MHPG, amitriptyline and affective disorders. A longitudinal study. Int Pharmacopsychiatry (1976) 0.80
Personality features related to generalized anxiety disorder. Compr Psychiatry (1990) 0.80
Simultaneous determination of clomipramine and its desmethyl and hydroxy metabolites in plasma of patients by high-performance liquid chromatography after solid-phase extraction. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.80
Effect of acute intravenous clomipramine and antiobsessional response to proserotonergic drugs: is gender a predictive variable? Biol Psychiatry (1999) 0.80
Neurocognitive functioning in bulimia nervosa: the role of neuroendocrine, personality and clinical aspects. Psychol Med (2010) 0.80
Panic attacks: a twin study. Psychiatry Res (1997) 0.80
Efficacy and safety of azithromycin 1 g once daily for 3 days in the treatment of community-acquired pneumonia: an open-label randomised comparison with amoxicillin-clavulanate 875/125 mg twice daily for 7 days. J Chemother (2008) 0.80
Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study. J Clin Psychopharmacol (1997) 0.80
Dizziness, migrainous vertigo and psychiatric disorders. J Laryngol Otol (2009) 0.79
Alpha reactivity in schizophrenia and in schizophrenic spectrum disorders: demographic, clinical and hemispheric assessment. Int J Psychophysiol (1989) 0.79
Dopamine function in obsessive-compulsive disorder: growth hormone response to apomorphine stimulation. Biol Psychiatry (1997) 0.79
Relationship between obsessive-compulsive personality disorder and obsessive-compulsive disorder. Compr Psychiatry (1997) 0.79